JN Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 90: 128-133, 2003. First published March 12, 2003; doi:10.1152/jn.01170.2002
0022-3077/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/1/128    most recent
01170.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, Y.
Right arrow Articles by Tonosaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, Y.
Right arrow Articles by Tonosaki, K.

Enhanced Responses of the Chorda Tympani Nerve to Sugars in the Ventromedial Hypothalamic Obese Rat

Yasutake Shimizu1,2, Mifumi Yamazaki1, Keiji Nakanishi1, Maki Sakurai1, Atsushi Sanada1, Tadashi Takewaki1,2 and Keiichi Tonosaki3

1Department of Veterinary Physiology, Faculty of Agriculture, and 2Department of Basic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, Gifu 501-1193; and 3Department of Oral Physiology, School of Dentistry, Meikai University, Saitama 350p-0283, Japan

Submitted 26 December 2002; accepted in final form 5 March 2003


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Sweet taste sensitivity in obese rats with lesions of the ventromedial hypothalamus (VMH) was studied by examining chorda tympani nerve responses to various taste stimuli including sugars. In the early progressive phase of obesity (2 wk after creating VMH lesions), there was no significant difference in the nerve responses to any taste stimulus between sham-operated and VMH-lesioned rats. In contrast, in the late phase of obesity (15–18 wk after VMH lesions), the magnitude of responses to sugars (except for fructose) was prominently greater than that in age-matched controls. High-fat diet-induced obese rats and streptozotocin-diabetic rats also showed greater chorda tympani nerve responses to sugars as was observed in VMH-lesioned obese rats, indicating that VMH lesions might not be specifically related to the enhanced gustatory neural responses to sugars. Although it has been demonstrated that the enhanced responses of the chorda tympani nerve to sugars in genetically diabetic db/db mice is largely attributable to the lack of the direct suppressive effect of leptin on the taste receptor cells, plasma leptin levels were not correlated with the changes in chorda tympani responsiveness to sugars in these models of obesity and diabetes. Accordingly, our results suggest that some chronic factors, including high blood glucose, inefficiency of insulin action, or leptin resistance may be related to the enhancement of chorda tympani nerve responses to sugars.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Destruction of the ventromedial area of hypothalamus (VMH) results in a chronic and persistent elevation of food intake, a hyperphagia that may exceed two to three times normal intake (Corbit and Stellar 1964Go; Graff and Stellar 1962Go; Weingarten 1982Go). A striking characteristic of VMH lesioned rats is their hyperreactivity to the stimulus properties of foods (Corbit and Stellar 1964Go; Graff and Stelilar 1962; Weingarten 1982Go). When given a relatively palatable diet including standard laboratory chow, they eat far more than normal animals. In contrast, if the palatability of the standard diet is reduced by the addition of quinine-HCl (QHCl), the hyperphagic animals reduce their food intake markedly, while normal animals maintain a relatively constant food intake. These feeding characteristics have been represented as "finickiness."

Although alteration in taste sensitivity and preference in VMH-lesioned rats have been well documented at the behavioral level, possible changes in peripheral taste nerve responsiveness accounting for the behavioral alterations are not known. In genetically diabetic db/db mice, it has been demonstrated that responses of the chorda tympani (CT) nerve to sugars are greater than those of lean control mice (Ninomiya et al. 1995Go). Recently, Kawai et al. (2000Go) showed that leptin directly suppresses the sensitivities of taste receptor cells to sweet substances. Thus it is rational to suppose that the enhanced responses of the CT nerve to sugars in db/db mice are due to defects of the suppressive effect of leptin, because these mice express a mutant leptin receptor (Chen et al. 1996Go; Chua et al. 1996Go; Lee et al. 1996Go). VMH-lesioned rats exhibit hyperleptimia as in db/db mice (Satoh et al. 1997Go; Suga et al. 1999Go, 2000Go), but leptin receptors in taste receptor cells would be unaffected by VMH destruction itself. Therefore it is of interest whether taste nerve responsiveness to sugars is elevated or not in VMH-lesioned rats to know the direct effects of leptin on taste-sensing mechanism more precisely.

In the present study, we recorded responses of the CT nerves of the VMH-lesioned rats to various taste stimuli including sugars. Our results showed that the VMH-lesioned rats possess greater sensitivities to sugars except for fructose but not to other taste stimuli than control rats. Additional experiments using dietary obese and streptozotocin (STZ)-induced diabetic rats indicate that some common metabolic impairments might be related to the enhanced gustatory neural responses to sugars in addition to the direct effects of leptin.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Subjects

We used female Wistar rats, weighing 180–230 g (6–7 wk old) at the time of delivery from Japan SLC (Shizuoka, Japan). They were housed individually in plastic cages at 22 ± 2°C (mean ± SD) with a 12:12-h light-dark cycle (light on 0700–1900 h) and given free access to laboratory chow (LABO MR Stock, Nihon-Nosan, Yokohama, Japan) and water. The rats were maintained in the laboratory for ≥2 wk after arrival to permit them to acclimate to their surroundings before experiments began (8–9 wk old, 250–300 g at the start of experiments).

The VMH was destroyed bilaterally by an electrolytic lesion according to the procedure described by Saito et al. (1985Go) with slight modifications. Briefly, rats were anesthetized with pentobarbital sodium (40 mg/kg ip) and were placed in the stereotaxic instrument and positioned with the nose bar set 5 mm above the interaural line. The electrode, consisting of an insulated stainless steel insect pin with exposed tip, was positioned 0.6 mm lateral to the Bregma and 9.0 mm below the skull surface. A direct anodal current of 1.2 mA for 4 s was passed through the electrode. The current pass was repeated three times with 30-s interval. For sham controls, the same surgical procedures were performed except that no current was passed. Only animals that developed hyperphagia and rapid gain in body weight compared with sham-lesioned rats were used. Sham-lesioned animals were used as controls for possible damage to nerve fibers by the procedure. We designated the early progressive phase of obesity as the dynamic phase (2 wk after creating VMH lesions) and the late phase of obesity as the static phase (15–18 wk after VMH lesions). At the end of the experiments, localization of the lesions was verified microscopically in serial frontal sections of the brain stained with cresyl violet.

Dietary obese rats and insulin-deficient diabetic rats have been also prepared to provide a comparison with VMH-lesioned rats. To induce dietary obesity, some rats were maintained on a high-fat diet for 18–20 wk. The high-fat diet contained the following (g/kg): 330 lard (Oriental Yeast, Tokyo), 50 corn oil (Oriental Yeast), 200 casein (Oriental Yeast), 225 corn starch (Oriental Yeast), 100 sucrose (Oriental Yeast), 50 cellulose (Oriental Yeast), 35 minerals (AIN76 mineral mixture; Oriental Yeast), and 10 vitamins (AIN76 vitamin mixture; Oriental Yeast). Control animals were given a standard laboratory chow (MR stock; Japan SLC, Shizuoka, Japan). Diabetic rats were made with a single-bolus intraperitoneal injection of STZ (60 mg/kg; Sigma, St. Louis, MO) dissolved in 0.1 M citric buffer (pH 4.2). The diabetic animals with fasting blood glucose concentrations of >300 mg/dl were remained untreated throughout the duration of the study.

Neural recording procedure

The CT nerve responses to various taste stimuli were recorded as previously described (Shimizu and Tonosaki 1999Go). The electrical activity of the whole CT nerve was fed to an AC amplifier and integrated with a time constant 1.0 s. The integrated electrical activity was led to and analyzed with PowerLab software (ADInstruments, Mountain View, CA). The height of steady-state responses of the integrated CT nerve activity, which were measured at 10 s after the onset of stimuli, were normalized to means of responses to 0.1 M NH4Cl being taken as unity (1.0). A series of taste stimulations was repeated at least three times, and the reproducible responses were considered to be the real responses of the respective rats.

Solutions used as chemical stimuli were (in M) 0.5 sucrose, 0.5 glucose, 0.5 fructose, 0.5 maltose, 0.05 NaCl, 0.01 HCl, 0.01 QHCl, and 0.05 monosodium glutamate (MSG). All of the test solutions were made fresh each week and refrigerated when not in use. The details of chemical stimulation procedures were described previously (Ogiso et al. 2000Go; Shimizu and Tonosaki 1999Go).

Measurements

Blood samples were obtained after a 6-h fast (9:00 AM to 3:00 PM). Plasma glucose levels were determined by the glucose oxidase method (Glucose B-test, Wako Pure Pharmaceutical, Osaka, Japan). Plasma insulin and leptin concentrations were determined by ELISA kits (Morinaga, Yokohama, Japan).

Statistical analysis

All values were presented as means ± SE. Statistical significance was examined by an ANOVA, with post hoc testing by means of Duncan's multiple range test. Comparisons between groups were made by Student's t-test.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
CT nerve responses to various taste stimuli in VMH-lesioned rats

Figure 1 shows integrated responses of the CT nerve to various taste stimuli in sham-operated and VMH-lesioned rats. In the dynamic phase (2 wk after creating VMH lesions), there was no significant difference in the nerve responses to any taste stimulus between sham-operated and VMH-lesioned rats (Fig. 1A). In contrast, the magnitude of response to sucrose in the static phase (15–18 wk after VMH lesions) was prominently greater than that in age-matched control (Fig. 1B). Magnitudes of responses to NaCl, HCl, QHCl, and MSG were unchanged even in the static phase (Fig. 1B).



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 1. Chorda tympani nerve responses to various taste stimuli in ventromedial area of hypothalamus (VMH)-lesioned rats. Representative recordings of the integrated responses from the chorda tympani nerve to various taste stimuli in dynamic phase (2 wk after creating VMH lesion; A) and static phase (15–18 wk after creating VMH lesions; B) are shown. Similar results were obtained in 5 independent experiments. Suc, sucrose; QHCl, quinine-HCl; MSG, monosodium glutamate.

 

In addition to sucrose, maltose, glucose, and fructose were also used as taste stimuli to see whether the enhancement of the CT nerve responsiveness is specific for sucrose or generalized for other sugars. As shown in Fig. 2A, the nerve responses to the four sugars were similar in both VMH-lesioned rats in the dynamic phase and their age-match sham-operated animals. In the static phase, relative magnitudes of responses to maltose and glucose, in addition to sucrose, were significantly larger than that in control animals, although no such difference was evident in response to fructose (Fig. 2B).



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 2. Relative responses to sugars in the chorda tympani of VMH-lesioned rats. Steady-state responses of the integrated chorda tympani nerve activity to sugars in dynamic phase (2 wk after creating VMH lesions; A) and static phase (15–18 wk after creating VMH lesions; B) were normalized to that to 0.1 M NH4Cl, which was taken as unity (1.0). The values were presented as means ± SE (n = 5). Suc, 0.5 M sucrose; Mal, 0.5 M maltose; Glc, 0.5 M glucose; Fru, 0.5 M fructose.

 

Plasma glucose, insulin, and leptin concentrations in dynamic and static phase of VMH-lesioned rats

Table 1 shows plasma glucose, insulin, and leptin concentrations in the dynamic and the static phases of VMH-lesioned rats. Plasma glucose levels did not significantly change in the dynamic phase, whereas it prominently increased in the static phase. VMH-lesioned rats in the dynamic phase had a 3-fold higher plasma insulin concentration and a 4.5-fold higher plasma leptin concentration than those in controls. These levels were further increased in the static phase. In sham-operated rats, plasma glucose and insulin levels were comparable at 2 and 15–18 wk after operation, but plasma leptin levels were significantly increased during this period.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Plasma glucose, insulin, and leptin levels in VMH-lesioned rats

 

Chorda tympani nerve responses to various taste stimuli in diet-induced obese rats and STZ-diabetic rats

The representative recordings of the CT nerve responses to various taste stimuli from rats maintained by high-fat diet and STZ-diabetic rats are shown in Figs. 3 and 4, respectively. As was observed in VMH-lesioned obese rats, high-fat diet-induced obese rats showed greater CT nerve response to sucrose than control rats, although such a difference was not evident in response to NaCl, HCl, QHCl and MSG (Fig. 3). In STZ-diabetic rats, there was no notable change in the CT nerve responses to any stimuli used, when the nerve responses were recorded 2 wk after STZ injection (data not shown). However, in rats maintained for 4 wk after STZ injection, the magnitude of response to sucrose was specifically increased as compared with vehicle-injected control (Fig. 4).



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 3. Chorda tympani nerve responses to various taste stimuli in high-fat diet-induced obese rats. Representative recordings of the integrated responses from the chorda tympani nerve to various taste stimuli in high-fat diet-induced obese rats are shown. Similar results were obtained in 5 independent experiments.

 


View larger version (16K):
[in this window]
[in a new window]
 
FIG. 4. The chorda tympani nerve responses to various taste stimuli in streptozotocin (STZ)-induced diabetic rats. The representative recordings of the integrated responses of chorda tympani nerve to various taste stimuli in STZ-induced diabetic rats are shown. Similar results were obtained in 5 independent experiments.

 

Relative magnitudes of responses to sucrose, maltose, glucose, and fructose in diet-induced obese and STZ-induced diabetic rats were shown in Fig. 5, A and B, respectively. Similar to VMH-lesioned rats in the static phase, responses to maltose and glucose were also significantly larger than those in control animals, although no such difference was observed in response to fructose.



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 5. Relative responses to sugars in the chorda tympani of high-fat diet-induced obese rats and STZ-induced diabetic rats. Steady-state responses of the integrated chorda tympani nerve activity to sugars in high-fat diet-induced obese rats (A) and STZ-induced diabetic rats (B) were normalized to that to 0.1 M NH4Cl, which was taken as unity (1.0). The values were presented as means ± SE (n = 5). Suc, 0.5 M sucrose; Mal, 0.5 M maltose; Glc, 0.5 M glucose; Fru, 0.5 M fructose.

 

Plasma glucose, insulin, and leptin concentrations in diet-induced obese rats and STZ-diabetic rats

Table 2 represents plasma glucose, insulin, and leptin concentrations in diet-induced obese and STZ-induced diabetic rats. In high-fat diet fed rats, these plasma parameters were significantly higher when compared with control rats that were maintained on a standard diet (Table 2, left). As expected, STZ-diabetic rats had fourfold higher plasma glucose concentration with a marked reduction of insulin levels (~15% of mean control values) when compared with control animals (Table 2, right). Plasma leptin was <0.5 ng/ml in all STZ-diabetic rats (Table 2, right).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Plasma glucose, insulin, and leptin levels in diet-induced obese and STZ-diabetic rats

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
In the present study, we investigated that the responses of the CT nerve of the VMH-lesioned rats to various taste stimuli. Our major findings are: the CT nerve responses to sugars except for fructose, but not to NaCl, HCl, QHCl, and MSG, are substantially increased in the VMH-lesioned obese rats, these changes were evident in the static phase of the VMH syndrome 15–18 wk after operation but not during the early progressive phase of obesity (the dynamic phase; 2 wk after creating VMH lesions), and the enhanced responsiveness to sugars of the CT nerves are common among the other obese and diabetic models (i.e., high-fat diet-induced obese and STZ-induced diabetic rats). In addition, measurements of plasma leptin concentrations in these obese and diabetic animals have revealed that changes in the responses of the CT nerve to sugars are not necessarily correlated with plasma leptin levels. Although it has been postulated that the enhanced sugar responsiveness in db/db mice is largely attributable to the lack of the direct suppressive effect of leptin on the taste receptor cells (Ninomiya et al. 1995Go, 2002Go), our results suggest some common metabolic impairments might be related to the enhanced CT nerve responses to sugars in addition to the direct effects of leptin.

Recently, it has been demonstrated that taste cells express the leptin receptor and that leptin directly increases K+ conductance, resulting in hyperpolarization and reduction of cell excitability (Kawai et al. 2000Go). Considering that db/db mice express a defective leptin receptor (Chen et al. 1996Go; Chua et al. 1996Go; Lee et al. 1996Go), it is reasonable to suppose that the enhancement of CT response to sugars is due to the lack of the suppressive effect of leptin. In accordance with this, intraperitoneal injection of leptin to db/db mice does not affect the CT nerve responses to sweeteners, whereas leptin substantially reduces those in lean control animals (Kawai et al. 2000Go). In the present study, we observed that the CT nerve responses to sugars in VMH-lesioned obese rats were greater than those in control rats. Similarly, high-fat diet-induced obese rats have greater responses to sugars as compared with rats maintained with a standard laboratory chow. These results conflict with the suppressive effect of leptin on taste reactivity to sugar because plasma leptin concentration of these rats is elevated as in db/db mice, but leptin receptors in taste cells are intact in contrast to db/db mice. This apparent discrepancy could be reconciled by supposing that leptin resistance is induced in taste cells. In fact, the early progressive phase of obesity was not accompanied by changes in CT nerve responses, suggesting that the enhancement of CT nerve responses to sugars is established on a time scale of several months. It is generally considered that a major mechanism for leptin resistance is a defect in the blood-brain-barrier transport system that delivers leptin to the sites of action in the hypothalamus (Caro et al. 1996Go; Schwartz et al. 1996Go; Van Heek et al. 1997Go). However, in addition to the defect in leptin access, it has been demonstrated that a signaling defect also exists in leptin-responsive hypothalamic neurons in the mice fed high fat diet (El-Haschimi et al. 2000Go). In addition, it has been shown recently that skeletal muscle become resistant to the direct effects of leptin, such as increase in lipid oxidation and triglycerol breakdown, during the development of obesity (Steinberg and Dyck 2000Go; Steinberg et al. 2002Go). It is thus possible that the leptin signaling pathway in the taste cells is down-regulated by prolonged hyperleptinemia in high-fat diet-induced obese rats as well as in VMH-lesioned obese rats.

We found that STZ-induced diabetic rats have higher CT nerve responses to sugars as in VMH-lesioned obese rats. This result seems to conflict with that reported by Ninomiya et al. (1995Go), who have demonstrated that STZ-induced diabetic mice show no significant difference in CT nerve responses to sugars compared with the control mice. This difference is probably derived from the difference in duration of diabetic state. In fact, we failed to observe significant changes in CT nerve responses to sugars 2 wk after STZ injection, whereas the enhancement of sugar responses of CT became evident after 4 wk of STZ injection. It should be noted, however, that the plasma leptin was reduced much by 2 wk after STZ injection (Table 2) (Havel et al. 1998Go). If leptin exerts a tonic inhibitory effect on sweet taste sensing mechanism in taste cells under the normal conditions, the reduction of circulating leptin may result in an increased sensitivity of taste cells immediately. The evidence that the time course of increase in CT responses to sugars does not coincide with a reduction of serum leptin level suggests that some chronic factors, including lowered leptin levels, alters the taste-sensing mechanism under the diabetic and obese conditions.

At present, the putative chronic factors that affect the sugar-sensing system in taste cells are not known. We speculate, however, that a chronic increase in plasma glucose and reduction of insulin action are likely to underlie the altered sensitivity of CT responses to sugars. Under the diabetic condition, tissue glucose utilization may be limited because of insulin deficiency or insulin resistance. Furthermore, persistent hyperglycemia has been known to reduce the brain blood flow and the glucose transport across the blood-brain barrier (Gjedde and Crone 1981Go; Harik and LaManna 1988Go; Matthaei et al. 1986Go; Pardridge et al. 1990Go), both of which would result in a lowered supply of glucose to the brain. Thus these conditions can be recognized as an insufficiency of intracellular glucose, in spite of the presence of excess extracellular glucose. Considering that enhancement of sugar responsiveness of CT is correlated with an increase in sugar intake behavior (Ninomiya et al. 1995Go, 2002Go), the enhancement of CT nerve responses to sugars in diabetic rats is inferred to be an adaptive change to satisfy the demand for glucose of brain and peripheral tissues. In accordance with this, we found that VMH-lesioned obese rats showed a strong preference for starch, which is a source of glucose but possesses different taste quality than sugars (Y. Shimizu, T. Takewaki, and K. Tonosaki, unpublished observation).

One of the characteristics observed commonly among VMH-lesioned obese rats, high-fat diet-induced obese rats and STZ-diabetic rats is that CT nerve responses to fructose were unchanged in contrast to those to glucose, sucrose, and maltose. Several lines of evidences have suggested that there are multiple receptor sites for sugars in taste cells (Beidler and Tonosaki 1985Go; Jakinovich 1976Go; Jakinovich and Goldstein 1976Go; Tonosaki and Funakoshi 1984Go, 1989Go). Recently, receptors for sweet taste stimuli including sugars were identified as T1Rs (Li et al. 2002Go; Margolskee 2002Go; Nelson et al. 2001Go). However, in contrast to bitter taste receptors T2Rs that constitute a large multigene family (Adler et al. 2000Go; Chandrashekar et al. 2000Go; Matsunami et al. 2000Go), T1Rs family is small and the only one form of functional sweet receptor is known to be a heterodimer of T1R2 and T1R3 (Li et al. 2002Go; Nelson et al. 2001Go). Available data have suggested that the heterodimer of T1R2 and T1R3 can be activated by most of sweet-tasting substances including fructose, glucose, sucrose, and maltose (Li et al. 2002Go). Thus the molecular basis for the multiple receptor sites for sugars is not so far established. Since several G protein {alpha}-subunits have been identified in taste receptor cells (Kusakabe et al. 1998Go; McLaughlin et al. 1992Go; Ruiz-Avila et al. 1995Go), it is possible that coupling patterns of the T1Rs and G proteins is related to the sweet taste specificity. In fact, co-expression experiments of T1R2/T1R3 complex with various G{alpha}15 chimeras in which the five-residue C-terminal tail was replaced by those of other G proteins showed that sucrose induced an increase in intracellular calcium when some specific chimeras were present (Li et al. 2002Go). Although the precise mechanism for the fructose-sensing system is not clear, it may be separate from other sugar receptors, and the factors that promote enhancement of responsiveness for glucose, sucrose, and maltose are ineffective for this putative fructose-sensing mechanism. In support of this notion, it has been reported that preabsorptive recognition of fructose and glucose in small intestine is made in a different manners (Mei 1978Go, 1985Go).

Physiological significance of the differences of the responses between fructose and other sugars are not known. It has been demonstrated that fructose ingestion induces insulin resistance and hyperlipidemia in rats (Elliott et al. 2002Go). This disadvantage of fructose as an energy source may be related to the lack of adaptive changes in taste sensing system for fructose. In accordance with this, our preliminary experiments with two-bottle preference tests (glucose vs. fructose) show that the relative preference of glucose solution was increased day by day, and the rats become to drink glucose solution exclusively within a week (Y. Shimizu, T. Takewaki, and K. Tonosaki, unpublished observation).

One of the striking characteristics of VMH-lesioned rats is their hyperreactivity to QHCl adulterated in foods (Corbit and Stellar 1964Go; Graff and Stelilar 1962; Weingarten 1982Go). We failed to detect changes in CT nerve responses to QHCl in VMH-lesioned rats. It should be mentioned, however, that changes in ingestive behavior are not necessarily accompanied by the corresponding changes in taste nerve reactivity. Accordingly, it seems likely that hyperreactive behavior to QHCl in VMH-lesioned rats depends on the differential responsiveness of higher centers that receive taste information. Further study is needed to establish the neurophysiological bases for finickiness of VMH-lesioned obese rats.

In summary, the present study shows that the responsiveness of the CT nerve to sugars is enhanced during the development of diabetes and obesity. Although leptin is established as an important regulator of the sweet-taste-sensing system, our results have suggested that some chronic factors, including high blood glucose, inefficiency of insulin action, or leptin resistance may be related to the enhancement of CT nerve responses to sugars.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests: Correspondence to be sent to: Prof. Tadashi Takewaki, Department of Veterinary Physiology, Faculty of Agriculture, Gifu University, Gifu 501-1193, Japan Tel: (81)58–293-2940 Fax: (81)58–293-2940 E mail: tt{at}cc.gifu-u.ac.jp


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Adler E, Hoon MA, Mueller KL, Chandrashekar J, Ryba NJ, and Zuker CS. A novel family of mammalian taste receptors. Cell 100: 693–702, 2000.[ISI][Medline]

Beidler LM and Tonosaki K. Multiple sweet receptor sites and taste theory. In: Taste, Olfaction, and the Central Nervous System, edited by Pfaff DW. New York: The Rockefeller University Press, 1985, p. 47–64.

Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, and Considine RV. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348: 159–161, 1996.[ISI][Medline]

Chandrashekar J, Mueller KL, Hoon MA, Adler E, Feng L, Guo W, Zuker CS, and Ryba NJ. T2Rs function as bitter taste receptors. Cell 100: 703–711, 2000.[ISI][Medline]

Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, and Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491–495, 1996.[ISI][Medline]

Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, and Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271: 994–996, 1996.[Abstract]

Corbit JD and Stellar E. Palatability, food intake, and obesity in normal and hyperphagic rats. J Comp Physiol Psychol 58: 63–67, 1964.[ISI][Medline]

Elliott SS, Keim NL, Stern JS, Teff K, and Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76: 911–922, 2002.[Abstract/Free Full Text]

El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, and Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105: 1827–1832, 2000.[ISI][Medline]

Gjedde A and Crone C. Blood-brain glucose transfer: repression in chronic hyperglycemia. Science 214: 456–457, 1981.[Abstract/Free Full Text]

Graff H and Stellar E. Hyperphagia, obesity, and finickiness. J Comp Physiol Psychol 55: 418–424, 1962.[ISI][Medline]

Harik SI and LaManna JC. Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia. J Neurochem 51: 1924–1929, 1988.[ISI][Medline]

Havel PJ, Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen CL, and Ahren B. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol Regulatory Integrative Comp Physiol 274: R1482–R1491, 1998.[Abstract/Free Full Text]

Jakinovich W Jr. Stimulation of the gerbil's gustatory receptors by disaccharides. Brain Res 110: 481–490, 1976.[ISI][Medline]

Jakinovich W Jr and Goldstein IJ. Stimulation of the gerbil's gustatory receptors by monosaccharides. Brain Res 110: 491–504, 1976.[ISI][Medline]

Kawai K, Sugimoto K, Nakashima K, Miura H, and Ninomiya Y. Leptin as a modulator of sweet taste sensitivities in mice. Proc Natl Acad Sci USA 97: 11044–11049, 2000.[Abstract/Free Full Text]

Kusakabe Y, Yamaguchi E, Tanemura K, Kameyama K, Chiba N, Arai S, Emori Y, and Abe K. Identification of two alpha-subunit species of GTP-binding proteins, Galpha15 and Galphaq, expressed in rat taste buds. Biochim Biophys Acta 1403: 265–272, 1998.[Medline]

Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, and Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632–635, 1996.[Medline]

Li X, Staszewski L, Xu H, Durick K, Zoller M, and Adler E. Human receptors for sweet and umami taste. Proc Natl Acad Sci USA 99: 4692–4696, 2002.[Abstract/Free Full Text]

McLaughlin SK, McKinnon PJ, and Margolskee RF. Gustducin is a taste-cell-specific G protein closely related to the transducins. Nature 357: 563–569, 1992.[Medline]

Margolskee RF. Molecular mechanisms of bitter and sweet taste transduction. J Biol Chem 277: 1–4, 2002.[Free Full Text]

Matsunami H, Montmayeur JP, and Buck LB. A family of candidate taste receptors in human and mouse. Nature 404: 601–604, 2000.[Medline]

Matthaei S, Horuk R, and Olefsky JM. Blood-brain glucose transfer in diabetes mellitus. Decreased number of glucose transporters at blood-brain barrier. Diabetes 35: 1181–1184, 1986.[Abstract]

Mei N. Vagal glucoreceptors in the small intestine of the cat. J Physiol 282: 485–506, 1978.[Abstract/Free Full Text]

Mei N. Intestinal chemosensitivity. Physiol Rev 65: 211–237, 1985.[Free Full Text]

Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, and Zuker CS. Mammalian sweet taste receptors. Cell 106: 381–390, 2001.[ISI][Medline]

Ninomiya Y, Sako N, and Imai Y. Enhanced gustatory neural responses to sugars in the diabetic db/db mouse. Am J Physiol Regulatory Integrative Comp Physiol 269: R930–R937, 1995.[Abstract/Free Full Text]

Ninomiya Y, Shigemura N, Yasumatsu K, Ohta R, Sugimoto K, Nakashima K, and Lindemann B. Leptin and sweet taste. Vitam Horm 64: 221–248, 2002.[ISI][Medline]

Ogiso K, Shimizu Y, Watanabe K, and Tonosaki K. Possible involvement of undissociated acid molecules in the acid response of the chorda tympani nerve of the rat. J Neurophysiol 83: 2776–2779, 2000.[Abstract/Free Full Text]

Pardridge WM, Triguero D, and Farrell CR. Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 39: 1040–1044, 1990.[Abstract]

Ruiz-Avila L, McLaughlin SK, Wildman D, McKinnon PJ, Robichon A, Spickofsky N, and Margolskee RF. Coupling of bitter receptor to phosphodiesterase through transducin in taste receptor cells. Nature 376: 80–85, 1995.[Medline]

Saito M, Minokoshi Y, and Shimazu T. Brown adipose tissue after ventromedial hypothalamic lesions in rats. Am J Physiol Endocrinol Metab 248: E20–E25, 1985.[Abstract/Free Full Text]

Satoh N, Ogawa Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Okazaki T, Tamaki M, Hayase M, Yoshimasa Y, Nishi S, Hosoda K, and Nakao K. Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138: 947–954, 1997.[Abstract/Free Full Text]

Schwartz MW, Peskind E, Raskind M, Boyko EJ, and Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2: 589–593, 1996.[ISI][Medline]

Shimizu Y and Tonosaki K. Low environmental temperature modulates gustatory nerve activity and behavioral responses to NaCl in rats. Am J Physiol Regulatory Integrative Comp Physiol 277: R368–R373, 1999.[Abstract/Free Full Text]

Steinberg GR and Dyck DJ. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol Endocrinol Metab 279: E1374–E1382, 2000.[Abstract/Free Full Text]

Steinberg GR, Parolin ML, Heigenhauser GJ, and Dyck DJ. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187–E192, 2002.[Abstract/Free Full Text]

Suga A, Hirano T, Inoue S, Tsuji M, Osaka T, Namba Y, Miura M, and Adachi M. Plasma leptin levels and triglyceride secretion rates in VMH-lesioned obese rats: a role of adiposity. Am J Physiol Endocrinol Metab E650–E657, 1999.

Suga A, Hirano T, Kageyama H, Osaka T, Namba Y, Tsuji M, Miura M, Adachi M, and Inoue S. Effects of fructose and glucose on plasma leptin, insulin, and insulin resistance in lean and VMH-lesioned obese rats. Am J Physiol Endocrinol Metab 278: E677–E683, 2000.[Abstract/Free Full Text]

Tonosaki K and Funakoshi M. The mouse taste cell response to five sugar stimuli. Comp Biochem Physiol 79A: 625–630, 1984.

Tonosaki K and Funakoshi M. Cross-adapted sugar responses in the mouse taste cell. Comp Biochem Physiol 92A: 181–183, 1989.

Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, and Davis HR Jr. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99: 385–390, 1997.[ISI][Medline]

Weingarten HP. Diet palatability modulates sham feeding in VMH-lesion and normal rats: inplications for finickiness and evaluation of sham-feeding data. J Comp Physiol Psychol 96: 223–233, 1982.[ISI][Medline]




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Hajnal, N. K. Acharya, P. S. Grigson, M. Covasa, and R. C. Twining
Obese OLETF rats exhibit increased operant performance for palatable sucrose solutions and differential sensitivity to D2 receptor antagonism
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1846 - R1854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Hajnal, M. Covasa, and N. T. Bello
Altered taste sensitivity in obese, prediabetic OLETF rats lacking CCK-1 receptors
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1675 - R1686.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/1/128    most recent
01170.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, Y.
Right arrow Articles by Tonosaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, Y.
Right arrow Articles by Tonosaki, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the The American Physiological Society.